RevMed

Home/Brands/BIOMERIEUX SA

BIOMERIEUX SA

Main Filters

BIOMERIEUX SA

BIOMERIEUX SA
CATALOG #	QTY	PRICE	DESCRIPTION
ETEST® Amikacin (AK)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Amoxicillin (AC)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Amoxicillin/clavulanic acid (2/1) (XL)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Ampicillin (AM)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Ampicillin/sulbactam (2/1) (AB)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Azithromycin (AZ)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Benzylpenicillin (PG)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Benzylpenicillin (PG)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® CEFACLOR	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Cefepime (PM)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® CEFOTAXIME	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Cefotaxime (CT)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Cefoxitin (FX)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® CEFTAZIDIME	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Ceftazidime (TZ)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® CEFTRIAXONE	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Ceftriaxone (TX)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Ceftriaxone (TX)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® CEFUROXIME	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Cephalothin (CE)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® CHLORAMPHENICOL	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Ciprofloxacin (CI)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® CLINDAMYCIN	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Daptomycin (DPC)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® DORIPENEM	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® ERTAPENEM	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Erythromycin (EM)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® FLUCONAZOLE	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant yeast. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Flucytosine (FC)	0	-	Etest is a quantitative technique for determining susceptibility of antifungal. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Gentamicin (GM)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® IMIPENEM	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® ITRACONAZOLE	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant yeast. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Levofloxacin (LE)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Linezolid (LZ)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® MEROPENEM	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Metronidazole (MZ)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Minocycline (MC)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Moxifloxacin (MX)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® OFLOXACIN	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® OXACILLIN	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® PIP/TAZO/CON-4	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® PIPERACILLIN	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® QUINUPRI/DALFO	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Rifampicin (RI)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Tetracycline (TC)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® TIC/CLAV-CON2	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® TIGECYCLINE	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® TOBRAMYCIN	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Trimethoprim/sulfamethoxazole (1/19) (TS)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Vancomycin (VA)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

326 Results

Results Per Page

Catalog #

AvailableQty

Starting At

Name

Company Name

Description

ETEST® Ceftazidime (TZ)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Ceftriaxone (TX)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Ceftriaxone (TX)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Cefoxitin (FX)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Cefotaxime (CT)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® CEFOTAXIME

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Cefepime (PM)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® CEFACLOR

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Cephalothin (CE)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Benzylpenicillin (PG)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Benzylpenicillin (PG)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Ampicillin/sulbactam (2/1) (AB)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Azithromycin (AZ)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Amikacin (AK)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Amoxicillin (AC)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Ampicillin (AM)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Amoxicillin/clavulanic acid (2/1) (XL)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® DORIPENEM

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Daptomycin (DPC)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® TIGECYCLINE

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® ERTAPENEM

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Linezolid (LZ)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Metronidazole (MZ)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Moxifloxacin (MX)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® QUINUPRI/DALFO

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Levofloxacin (LE)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Rifampicin (RI)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® ITRACONAZOLE

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant yeast. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Vancomycin (VA)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Trimethoprim/sulfamethoxazole (1/19) (TS)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® TIC/CLAV-CON2

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Tetracycline (TC)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® TOBRAMYCIN

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® PIPERACILLIN

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® PIP/TAZO/CON-4

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® OXACILLIN

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® OFLOXACIN

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Minocycline (MC)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® MEROPENEM

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® IMIPENEM

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Gentamicin (GM)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Flucytosine (FC)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of antifungal. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® FLUCONAZOLE

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant yeast. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Erythromycin (EM)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® CLINDAMYCIN

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Ciprofloxacin (CI)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® CHLORAMPHENICOL

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® CEFUROXIME

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® CEFTAZIDIME

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® CEFTRIAXONE

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.